Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Zim Laboratories Ltd. (ZIMLAB) Stock Price & Analysis

ZIMLAB Stock Chart & Stats

₹134.77-₹1.52(-1.12%)
At close: 3:30 PM GMT+5:30
₹125₹15010 Aug24 Aug7 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
INR 132.60 - INR 137.50
52-Week Range
INR 59.72 - INR 160.10
Previous Close
INR 136.45
Volume
N/A
Average Volume (3M)
11.73K
Market Cap
INR 7.32B
Enterprise Value
INR 3.78B
Total Cash (Recent Filing)
INR 402.52M
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
162.0
Beta
1.10
Next Earnings
Nov 04, 2026 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Sep 19, 2019
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Diversified Pharma Platform

The company combines formulation development, manufacturing and marketing across oral solid and patient-friendly delivery formats. This integrated platform can support product expansion across therapeutic areas and provides a foundation for serving both domestic and international pharmaceutical demand over multiple quarters.

Domestic And Export Reach

Exposure to both Indian and international markets broadens the company’s commercial reach and reduces reliance on a single sales channel. Its combination of branded and generic medicines, institutional business and commercial distribution can support more durable market access.

Supported Balance Sheet

Rising equity alongside moderate leverage provides a comparatively sound financial base for ongoing operations and investment. This gives Zim Laboratories more resilience than a highly levered structure and preserves some flexibility while profitability remains under pressure.

Bears Say

Profitability Decline

The sharp reduction in net income and operating profit indicates that recent revenue is generating less earnings than before. If weaker profitability persists, internal funding capacity may remain constrained and the company’s ability to convert its operating platform into durable shareholder returns will be reduced.

Negative Free Cash Flow

Recurring volatility in free cash flow, including a return to negative generation, weakens the quality of reported earnings and limits self-funded investment. Even with positive operating cash flow, continued cash outflows could restrict capital allocation flexibility across the next several quarters.

Inconsistent Growth And Returns

The recent growth record shows limited and inconsistent top-line expansion, while declining returns on equity suggest that additional capital is producing less profit. Together, these trends point to weaker operating efficiency and make sustained improvement in earnings power less certain.

Zim Laboratories Ltd. News

ZIMLAB FAQ

What was Zim Laboratories Ltd.’s price range in the past 12 months?
Zim Laboratories Ltd. lowest stock price was ₹59.72 and its highest was ₹160.10 in the past 12 months.
What is Zim Laboratories Ltd.’s market cap?
Zim Laboratories Ltd.’s market cap is ₹7.32B.
When is Zim Laboratories Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Zim Laboratories Ltd.’s earnings last quarter?
Zim Laboratories Ltd. released its earnings results on Aug 06, 2026. The company reported -₹0.75 earnings per share for the quarter.
Is Zim Laboratories Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Zim Laboratories Ltd. pay dividends?
Zim Laboratories Ltd. pays a Annually dividend of ₹0.167 which represents an annual dividend yield of ―. See more information on Zim Laboratories Ltd. dividends here
What is Zim Laboratories Ltd.’s EPS estimate?
Zim Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zim Laboratories Ltd. have?
Zim Laboratories Ltd. has 53,658,490 shares outstanding.
What happened to Zim Laboratories Ltd.’s price movement after its last earnings report?
Zim Laboratories Ltd. reported an EPS of -₹0.75 in its last earnings report. Following the earnings report the stock price went up 0.175%.
Which hedge fund is a major shareholder of Zim Laboratories Ltd.?
Currently, no hedge funds are holding shares in IN:ZIMLAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology